Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04699279
NA

Protective Effect of Statin Against Negative Cardiovascular Remodeling and Organ Dysfunction After Acute Aortic Syndrome Surgery (PANDA III)

Sponsor: Nanjing Medical University

View on ClinicalTrials.gov

Summary

Acute Aortic Syndrome (AAS)/Aortic Aneurysm is a common feature of aortic wall events, including aortic dissection, intramural hematoma, aortic ulceration and aortic trauma, and occurs in up to 35 cases per 100,000 cases per year between the ages of 65 and 75 years. Increased levels of the inflammatory biomarker high-sensitivity C-reactive protein predict cardiovascular events. Since statins lower levels of high-sensitivity C-reactive protein as well as cholesterol, the authors hypothesized that people with acute aortic syndrome but without hyperlipidemia might benefit from statin treatment.

Key Details

Gender

All

Age Range

18 Years - 85 Years

Study Type

INTERVENTIONAL

Enrollment

300

Start Date

2021-01-01

Completion Date

2024-12-31

Last Updated

2024-12-13

Healthy Volunteers

No

Interventions

DRUG

Rosuvastatin 10mg

Rosuvastatin 10mg is taken by oral or nasal feeding every day at ang time.

Locations (5)

The First Affiliated Hospital of Guangzhou Medical University

Guangzhou, Guangdong, China

The first affiliated hospital of nanjing medical university

Nanjing, Jiangsu, China

Affiliated Hospital of Qingdao University

Qingdao, Shandong, China

West China Hospital of Sichuan University

Chengdu, Sichuan, China

Beijing Anzhen Hospital

Beijing, China